Session: Materials and Process Development for Hybrid Therapeutics

This session is focused on the recent advances and challenges in the discovery, development and manufacturing of antibody drug conjugates (ADCs) and other hybrid therapeutics. The topics to be discussed include advances in protein optimization and expression, conjugation, purification and formulation strategies, advances and challenges in the development of robust and scalable processes, implementation of Process Analytical Technologies (PAT) for process monitoring, and utilization of single-use technologies in manufacturing.